Compare Crispr Therapeutics AG (CRSP) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Reddit Inc — how do they compare? Crispr Therapeutics AG trades at $53.95 (market cap $5.23B), while Reddit Inc trades at $153.39 (market cap $30.05B). The key difference: Reddit Inc is far larger — about 5.7× Crispr Therapeutics AG's market cap. Which is the better fit depends on your goals.
| CRSP | RDDT | |
|---|---|---|
Market Cap | $5.23B | $30.05B |
Sector | Health | Media |
52-Week High | $76.78 | $270.71 |
52-Week Low | $44.34 | $121.84 |
Enterprise Value | $3.65B | $27.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRISPR Therapeutics (CRSP) trades at $54.02, up 0.95% on the day, with strong technical momentum and bullish moving average signals. The company reported a Q2 2026 loss of $0.94 per share, beating estimates, while revenue growth is driven by CASGEVY sales expansion. Analyst sentiment remains positive with a $82.67 consensus price target representing 53% upside potential.
Despite promising pipeline developments and strong analyst support, CRSP faces significant fundamental challenges including negative profit margins, substantial cash burn, and high valuation multiples. The stock's near-term performance will depend on successful clinical trial outcomes and commercial execution of its gene-editing therapies.
Reddit (RDDT) trades at $154.14, down 2.87% over 24 hours, amid bearish technical signals despite strong fundamentals. The stock shows robust revenue growth, with Q2 2026 earnings beating estimates by 31.6% and a net income margin of 31.35%. Recent news highlights CEO stock sales and AI integration efforts, while technical indicators point to resistance near $160.
Outlook remains positive based on analyst consensus with a $220.25 price target, though risks include search traffic volatility and competitive pressures. The stock's current valuation offers potential upside if user monetization and AI initiatives drive future earnings, but investors should monitor quarterly performance for sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
